Global Drugs for Immunotherapy Market Report 2021 - Opportunities And Strategies, Market Forecast And Trends
26 Nov, 2021
Check out TBRC’s sale today for
The drugs for immunotherapy market consist of sales of immunotherapy drugs. Immunotherapy drugs help the immune system to fight cancer by stimulating the immune system of the body and generate an immune response aiding the production of antibodies.
Global Drugs for Immunotherapy Market Size And Drivers:
The global drugs for immunotherapy market is expected to grow from $149.31 billion in 2020 to $160.43 billion in 2021 at a compound annual growth rate (CAGR) of 7.4%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The drugs for immunotherapy market is expected to reach $248.27 billion in 2025 at a CAGR of 11.5%. The immunotherapy drugs market is being driven by rising incidences of cancer globally.
Request For A Sample For The Global Drugs for Immunotherapy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2559&type=smp
Trends In The Global Drugs for Immunotherapy Market
Manufacturers of immunotherapy drugs are increasingly collaborating or partnering with other companies to share technology, resources, product knowledge and expand business. For example, Illumina Inc. and Bristol-Myers Squibb (BMS) collaborated to utilize Illumina’s next-generation sequencing (NGS) technology to develop and commercialize in-vitro diagnostic (IVD) assays in support of Bristol-Myers Squibb's oncology portfolio. Allogene Therapeutics Inc. and Pfizer Inc. entered into an asset contribution agreement to use Pfizer’s portfolio of assets related to allogeneic CAR-T therapy.
Global Drugs for Immunotherapy Market Segments:
The global drugs for immunotherapy market is further segmented –
By Type: Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors, Others
By Therapy Area: Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Others
By End User: Hospitals & Clinics, Ambulatory Surgical Centers, Others
By Geography: The global drugs for immunotherapy market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Report For The Global Drugs for Immunotherapy Market At:
https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-reportDrugs for Immunotherapy Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides drugs for immunotherapy market overviews, analyzes and forecasts market size and growth for the global drugs for immunotherapy market, drugs for immunotherapy market share, drugs for immunotherapy market players, drugs for immunotherapy market segments and geographies, drugs for immunotherapy market’s leading competitors’ revenues, profiles and market shares. The drugs for immunotherapy market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.